Skip to main content
Clinical Trials/ISRCTN16865847
ISRCTN16865847Active, not recruitingUnknown

Exploring the benefits of wearable electronic vision enhancement systems for people with age-related macular degeneration. A randomised crossover trial.

Macular Society0 sites40 target enrollmentStarted: March 30, 2023Last updated:
Conditions

Trial Snapshot

Phase
Unknown
Status
Active, not recruiting
Sponsor
Enrollment
40

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Sex
All

Inclusion Criteria

  • •1. People who are aged 18 years or over
  • •2. Vision loss primarily due to AMD and affects their daily life
  • •3. Able to undertake assessments in English
  • •4. Pass on the short form Mini-mental State Evaluation (MMSE: adapted for vision loss).
  • •5. Not a current wEVES user

Exclusion Criteria

  • •1. Under 18 years of age
  • •2. Other forms of maculopathy or significant causes of vision impairment
  • •3. Reported significant deterioration in vision in the two months before entry
  • •4. Planned curative ocular surgery (e.g. cataract operation) in the study time
  • •5. Balance-related disorders
  • •6. Hearing loss significant enough to affect answering telephone questions

Investigators

Sponsor
Macular Society

Similar Trials

Exploring the benefits of wearable... | Clinical Trial